FDA Adds Important Safety Information to Xolair Label
An FDA review of safety studies suggests a slightly increased risk of problems involving the heart and blood vessels supplying the brain among patients being treated with the asthma drug Xolair (omalizumab) than in those who were not treated with Xolair.
Rx Lowered Steroid Dose in Asthma Patients
Oral corticosteroids are a common treatment for asthma, but they often come with unwanted side effects. One recent study showed that another medication may help patients lower their corticosteroid dose over time.